![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 403/12 | |
C07D 401/14 | |||
C07D 405/14 | |||
C07D 409/14 | |||
C07D 417/14 | |||
A61K 31/4025 | |||
A61P 3/00 | |||
A61P 35/00 | |||
A61P 39/00 |
(11) | Patento numeris | 3063141 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 14802535.6 |
Europos patento paraiškos padavimo data | 2014-10-28 | |
(97) | Europos patento paraiškos paskelbimo data | 2016-09-07 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-02-28 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2014/062516 |
Data | 2014-10-28 |
(87) | Numeris | WO 2015/065937 |
Data | 2015-05-07 |
(30) | Numeris | Data | Šalis |
201361897110 P | 2013-10-29 | US |
(72) |
WANG, Bing, US
|
(73) |
BioMarin Pharmaceutical Inc.,
105 Digital Drive, Novato, CA 94949,
US
|
(54) | N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS |
N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS |